Antimicrobial Therapy for Life-threatening Infections: Speed is Life-Reference-Cited by-同舟云学术

Antimicrobial Therapy for Life-threatening Infections: Speed is Life

Published:2011-01 Issue:1 Volume:27 Page:53-76
ISSN:0749-0704
Container-title:Critical Care Clinics
language:en
Short-container-title:Critical Care Clinics

Author:

Funk Duane J.,Kumar Anand

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine,General Medicine

Reference111 articles.

1. The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma;Blow;J Trauma,1999

2. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour;Boersma;Lancet,1996

3. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism;Wood;Chest,2002

4. Practice guidelines for the management of bacterial meningitis;Tunkel;Clin Infect Dis,2004

5. Quality of care, process, and outcomes in elderly patients with pneumonia;Meehan;JAMA,1997

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge, management, and complications of sepsis and septic shock: A significant therapeutic challenge in the intensive care unit;Journal of Acute Disease;2024-04

2. Carba PBP: a novel penicillin-binding protein-based lateral flow assay for rapid phenotypic detection of carbapenemase-producing Enterobacterales;Journal of Clinical Microbiology;2024-02-14

3. Analysis of the structure of bacteremia and sensitivity to antibiotics of microorganisms isolated in intensive care units in an emergency hospital in the period from 2003 to 2021: a retrospective observational study;Annals of Critical Care;2023-04-28

4. MALDI‐TOF mass spectrometry rapid pathogen identification and outcomes of patients with bloodstream infection: A systematic review and meta‐analysis;Microbial Biotechnology;2022-08-03

5. Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia;Journal of Antimicrobial Chemotherapy;2022-01-12